Form 4: AIM ImmunoTech Director Acquires Shares in Lieu of Cash Compensation

Nancy Bryan, a director at AIM ImmunoTech Inc., acquired 26,305 shares of common stock on December 31, 2024, in lieu of cash compensation under the company's Cash Conservation Plan.

Summary

• On December 31, 2024, Nancy Bryan, a director of AIM ImmunoTech Inc., acquired 26,305 shares of common stock.
• The acquisition was made in lieu of director compensation, as part of the issuer's Cash Conservation Plan.
• The price per share was $0.198.
• Following the transaction, Bryan directly owns 111,864 shares of AIM ImmunoTech Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment. While a director acquiring shares can be seen as positive, the context of a Cash Conservation Plan raises concerns about the company's financial health.

Positives

• Director's acceptance of shares in lieu of cash compensation demonstrates confidence in the company's future.

Risks

• The Cash Conservation Plan suggests the company may be facing financial constraints.

Industry Context

Directors sometimes take shares instead of cash to reduce the cash burden on the company. This is a common practice in smaller companies or those facing financial challenges.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director may be viewed positively, but the Cash Conservation Plan could raise concerns.
• Employees: The Cash Conservation Plan may impact employee compensation or benefits.

Key Dates

Keywords

AIM ImmunoTech, Director, Share Acquisition, Form 4, Cash Conservation Plan, Compensation